dc.date.accessioned |
2020-10-21T06:46:23Z |
|
dc.date.available |
2020-10-21T06:46:23Z |
|
dc.date.issued |
2018 |
|
dc.date.issued |
2018/09/27 |
|
dc.identifier.citation |
Cecener G, Egeli U, Tunca B..Pharm Res. 2018 Sep 25;35(11):218. doi: 10.1007/s11095-018-2502-6. |
|
dc.identifier.uri |
http://doi.org/10.1007/s11095-018-2502-6 |
|
dc.identifier.uri |
https://hdl.handle.net/20.500.12619/71852 |
|
dc.description |
PMID = 30255456 |
|
dc.relation.isversionof |
10.1007/s11095-018-2502-6 |
|
dc.rights |
info:eu-repo/semantics/closedAccess |
|
dc.title |
Synthetically Lethal BMN 673 (Talazoparib) Loaded Solid Lipid Nanoparticles for BRCA1 Mutant Triple Negative Breast Cancer |
|
dc.type |
article |
|
dc.relation.journal |
Pharm Res |
|
dc.identifier.doi |
10.1007/s11095-018-2502-6 |
|
dc.contributor.author |
Guney Eskiler G |
|
dc.contributor.author |
Cecener G |
|
dc.contributor.author |
Egeli U |
|
dc.contributor.author |
Tunca B. |
|
dc.relation.publicationcategory |
Makale - Uluslararası Hakemli Dergi |
|